Product Document Searching Made Easy by 2D Code! | TCI Materials Science News November 2025 | [TCIPracticalExample] Ullmann-type Coupling Reaction at Room Temperature... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 24386-93-4 | Product Number: I1156
5-Iodotubercidin
Purity: >98.0%(T)(HPLC)
Synonyms:
- 7-Deaza-7-iodoadenosine
- 5-Iodo-7-β-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- 4-Amino-5-iodo-7-β-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidine
- 7-Iodo-7-deazaadenosine
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time | Quantity |
Shipping Information
|
|---|---|---|---|---|---|---|
| 200MG |
S$246.00
|
23 | 0 | Contact Us |
|
* Please contact our distributors or
TCI
to order TCI products.
* The storage conditions are subject to change without notice.
| Product Number | I1156 |
Purity / Analysis Method
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__1H__1__3IN__4O__4 = 392.15 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Heat Sensitive |
| CAS RN | 24386-93-4 |
| Reaxys Registry Number | 4543232 |
| MDL Number | MFCD00055131 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Volumetric Analysis) | min. 98.0 % |
| NMR | confirm to structure |
Properties (reference)
| Maximum Absorption Wavelength | 284 nm (MeOH) |
GHS
Related Laws:
Transport Information:
| H.S.code* | 2934.99-000 |
Application
5-Iodotubercidin: A General Protein Kinase Inhibitor
5-Iodotubercidin is a potent and competitive adenosine protein kinase inhibitor. It has been reported that 5-iodotubercidin inhibits CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2, PKC, and nucleoside transporter.1-3) 5-iodotubercidin also inhibits LRRK2 (Leucine-rich repeat kinase 2) –G2019S that is a promising therapeutic target for the treatment of Parkinson's disease.4) There is a recent report, that 5-Iodotubercidin inhibits SARS-CoV-2 RNA-dependent RNA polymerase (RdRp).5) (The product is for research purpose only.)
References
- 1) Identification of the glycogenic compound 5-iodotubercidin as a general protein kinase inhibitor
- 2) Effects of iodotubercidin on adenosine kinase activity and nucleoside transport in DDT MF-2 smooth muscle cells
- 3) Adenosine Kinase Inhibitors. 1. Synthesis, Enzyme Inhibition, and Anti-seizure Activity of 5-Iodotubercidin Analogue
- 4) Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
- 5) 5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.
